`

Deurali-Janta Pharmaceuticals Pvt. Ltd

Pharmaceutical Manufacturing

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Deurali-Janta Pharmaceuticals Pvt. Ltd

What does Deurali-janta pharmaceuticals pvt. ltd do?+

The company started its operations in Jan 1991 with general products like antipyretics, anti-inflammatory, antibiotics and vitamins etc. With the growing number of pharmaceutical companies DJPL has successfully remained at the forefront modifying its overall philosophies with time. DJPL is the first pharmaceutical company to start technological collaboration in Nepal. In 1995 it strengthened its technological capacity at par with international standards by starting Technological Transfer Agreement with Renata Limited, Bangladesh which was formerly Pfizer Laboratories Bangladesh Limited. The product range of DJPL includes from general products to cardiac, anti-diabetics, nephrology, gynecological and dermatological medicines. Deurali-Janta believes in the development...

What is Deurali-janta pharmaceuticals pvt. ltd's industry? +

Deurali-janta pharmaceuticals pvt. ltd operates in the Pharmaceutical manufacturing industry.

What is Deurali-janta pharmaceuticals pvt. ltd's revenue? +

Deurali-janta pharmaceuticals pvt. ltd's revenue is 11m - 100m

What is Deurali-janta pharmaceuticals pvt. ltd's company size? +

Deurali-janta pharmaceuticals pvt. ltd has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.